Medical Decision Making Policy & Practice (MDM P&P) is an open access journal that focuses on research that addresses current problems in health care policy and practice. The journal offers rigorous and systematic applications of decision science that are designed to improve the health and clinical care of individuals and to assist with health-policy development. MDM P&P focuses on the application of current theories, methods, and approaches from a variety of disciplines to important problems facing clinical and health policy decision makers, including patients, providers, producers, and payers.
PMC indexing is a top priority for MDM P&P, and all necessary steps are being taken to attain this.
This journal is a member of the Committee on Publication Ethics (COPE).
Medical Decision Making Policy & Practice (MDM P&P) offers rigorous and systematic applications of decision science that are designed to improve the health and clinical care of individuals and to assist with health-policy development. MDM P&P focuses on the application of current theories, methods, and approaches from a variety of disciplines to important problems facing clinical and health policy decision makers, including patients, providers, producers, and payers.
MDM P&P focuses on important topics such as:
• Optimal strategies for patient care and policy decision-making for specific health conditions
• Approaches to improving individual and group medical decision-making processes
• Shared decision making and patient decision support
• Decision and cost-effectiveness analyses
• Health technology assessment
• Examples of teaching decision-making
We are most interested in manuscripts that are exemplary applications of standard methods to important problems.
MDM and MDM Policy & Practice
Although Medical Decision Making publishes applied research that advances the theory and methods of decision science, MDM Policy & Practice focuses more squarely on research that addresses current problems in health care policy and practice. If you want to report the impact of a patient decision aid for lung cancer screening, the cost-effectiveness of a new heart valve, or health-state valuations for a new population, MDM P&P is for you. If you want to compare methods for conducting value-clarification exercises, better modeling of survival curves, or the impact of new utility theories on health-state valuation, consider MDM instead. Authors who are unsure which SMDM journal they should submit their work to may opt in for consideration by both journals during manuscript submission.
MDM publishes using a hybrid publication model. By default, manuscripts accepted to MDM are published online and in print and are accessible to all SMDM members, institutional subscribers, MDM subscribers, and those who opt to pay a per-article download fee. MDM also offers authors an open access option for published articles. For an article-processing charge, SAGE Choice allows authors to make their work freely available to all readers online.
MDM P&P publishes using a fully open-access model in which authors of all manuscripts accepted for publication pay an article-processing charge. All published articles are freely available to all readers online only; MDM P&P does not publish in print. Open access enables articles to receive broader and more diverse visibility and citation than is typically possible with more traditional, subscription-based publishing.
MDM P&P publishes original research articles, reviews, case studies, letters to the editor, and editorials. MDM P&P does not consider previously published articles for publication. Word counts are suggested lengths, rather than firm limits, but authors are encouraged to remain within them.
• Original research articles (1,500-4,500 words). Original research articles describe studies of decision making focused on clinical or policy applications.
• Reviews (3,500 words). MDM P&P considers systematic reviews as well as informal, narrative reviews addressing research questions relating to applications of medical decision making.
• Case studies (3,000-5,000 words). Case studies illustrate the application of a decision model to an actual patient or patient group, or the role of a specific decision model, cost-effectiveness analysis, or other type of mathematical model in an actual policy decision, including, for example, a clinical practice guideline or a national coverage policy decision. The ideal case study includes detailed information about the problem addressed, collaboration among modelers and decision makers in framing questions, the development and results of the model, and how the model influenced (or failed to influence) a decision.
• Letters to the Editor (1,000 words). Letters in response to articles published in MDM P&P within the last year will be considered.
• Editorials (1,500 words). The journal publishes editorials, which are considered as a result of a presubmission inquiry or invitation only.
|Kenneth J. Smith, MD, MS||University of Pittsburgh (Pittsburgh, Pennsylvania, United States)|
|Neal V. Dawson, MD||Case Western Reserve University, USA|
|Mark Helfand, MD, MPH||Oregon Health & Sciences University (Portland, Oregon, USA)|
|Harold C. Sox, MD, MACP||Dartmouth College (Hanover, New Hampshire, USA)|
|Jessica S. Ancker, MPH, PhD||Cornell University (New York City, NY, USA)|
|Stefano Conti, MSc, PhD||Public Health England (London, England, UK)|
|Elisabeth Fenwick, MSc, PhD||ICON Plc (United Kingdom)|
|Jeremy D. Goldhaber-Fiebert, PhD||Stanford University (Stanford, California, United States)|
|Richard Grieve||London School of Hygiene & Tropical Medicine (London, United Kingdom)|
|Peder A. Halvorsen||University of Tromsø (Alta, Norway)|
|Olga Kostopoulou, MSc, PhD||Imperial College London (London, United Kingdom)|
|Ivar Sønbø Kristiansen, MD, PhD, MPH||University of Oslo (Oslo, Norway)|
|Josephine A. Mauskopf, PhD, MHA||RTI International (Research Triangle Park, North Carolina, United States)|
|Eleanor M. Pullenayegum, PhD||University of Toronto (Toronto, Ontario, Canada)|
|Donald A. Redelmeier, MD||University of Toronto (Toronto, Ontario, Canada)|
|Louise B. Russell, PhD||Rutgers University (New Brunswick, New Jersey, USA)|
|Marilyn M. Schapira, MD, MPH||University of Pennsylvania (Philadelphia, Pennsylvania, United States)|
|Paul A. Scuffham||Griffith University (Meadowbrook, Queensland, Australia)|
|Victoria A. Shaffer, PhD||University of Missouri (Columbia, Missouri, United States)|
|Anushua Sinha, MD, MPH||Rutgers University (Newark, New Jersey, USA)|
|James E. Stahl, MD, CM, MPH||Dartmouth College (Lebanon, New Hampshire, USA)|
|Ewout W. Steyerberg, MSc, PhD||Erasmus University (Leiden, Zuid-Holland, Netherlands)|
|Erika A. Waters, PhD, MPH||Washington University in St. Louis (St. Louis, Missouri, United States)|
|Nicky J. Welton, PhD||University of Bristol (Bristol, United Kingdom)|
|Feng Xie, BSc, MSc, PhD||McMaster University (Hamilton, Ontario, Canada)|
|Brian J. Zikmund-Fisher, PhD||University of Michigan (Ann Arbor, Michigan, United States)|
|Dana L. Alden, PhD, MBA||University of Hawai'i at Manoa (Honolulu, Hawai'i, United States)|
|Wändi Bruine de Bruin, PhD, MSc||University of Leeds (Leeds, United Kingdom)|
|Jagpreet Chhatwal, PhD||Massachusetts General Hospital (Boston, Massachusetts, United States)|
|Benjamin Djulbegovic, MD, ScD, MSc||University of South Florida (Tampa, Florida, United States)|
|Darryl T. Gray, MD, ScD, FACC, FAHA||Agency for Healthcare Research and Quality (Rockville, Maryland, USA)|
|Scott D. Grosse, PhD||Centers for Disease Control and Prevention (Atlanta, GA, USA)|
|Janel Hanmer, MD, PhD||University of Pittsburgh (Pittsburgh, Pennsylvania, United States)|
|Felicity W. K. Harper, PhD||Wayne State University (Detroit, MI, USA)|
|Yoko Ibuka, PhD||Keio University (Sendai, Aoba-ku, Japan)|
|Robert L. Jayes, MD||The George Washington University, Washington, DC|
|Christopher McCabe, PhD, MSc||University of Alberta (Edmonton, Canada)|
|Stephen G. Pauker, MD||Tufts University (Medford, Massachusetts, USA)|
|Donna L. Rowen, PhD, MSc||University of Sheffield (Sheffield, United Kingdom)|
|Steven M. Shechter, PhD||University of British Columbia (Vancouver, Canada)|
|Mark Strong, MBChB, MPH, PhD||University of Sheffield (Sheffield, United Kingdom)|
|Eve Wittenberg, PhD, MPP||Harvard University (Boston, MA, USA)|
|Lazaros Andronis, PhD||University of Birmingham (Birmingham, United Kingdom)|
|Caroline Bascoul-Mollevi, PhD||UNICANCER (France)|
|Cornelia Betsch, PhD||University of Erfurt (Erfurt, Germany)|
|Kerri L. Cavanaugh, MD, MHS||Vanderbilt University (Nashville, Tennessee, USA)|
|Su-Hsin Chang, PhD, SM||Washington University in St. Louis (St. Louis, Missouri, United States)|
|Lauren E. Cipriano, PhD||University of Western Ontario (London, Ontario, Canada)|
|Elamin H. Elbasha, PhD||Merck & Co., Inc. (USA)|
|Paul K. J. Han, MD, MA, MPH||Maine Medical Center (USA)|
|Quang A. Le, PharmD, PhD||Western University of Health Sciences (Pomona, California, United States)|
|Nan Luo, PhD||National University of Singapore (Singapore)|
|Daniel D. Matlock, MD, MPH||University of Colorado (Denver, Colorado, United States)|
|Daniella Meeker, PhD||University of Southern California (Los Angeles, California, United States)|
|Wendy L. Nelson, MPH, PhD, RN||National Institutes of Health (Bethesda, Maryland, USA)|
|Daria O'Reilly, MSc, PhD||McMaster University (Hamilton, Ontario, Canada)|
|A. Simon Pickard, PhD||University of Illinois at Chicago (Chicago, Illinois, United States)|
|José Luis Pinto Prades, PhD, MSc||University of Navarra (Pamplona, Navarra, Spain)|
|Kim Rand-Hendriksen, PhD||University of Oslo (Oslo, Norway)|
|Carolyn M. Rutter, PhD||RAND Corporation (Santa Monica, California, USA)|
|David J. Vanness, PhD||University of Wisconsin–Madison (Madison, Wisconsin, United States)|
|Andrew J. Vickers, PhD||Memorial Sloan-Kettering Cancer Center (New York City, NY, USA)|
|Todd H. Wagner, PhD||Stanford University (Stanford, California, United States)|
|Jennifer A. Whitty, BPharm, Grad DipClinPharm, PhD||The University of Queensland (Brisbane, Queensland, Australia)|
|Pelham M. Barton, PhD||University of Birmingham (Birmingham, United Kingdom)|
|Robert Böhm, PhD||RWTH Aachen University (Aachen, Germany)|
|James V. Codella, MEng, PhD||IBM Research (Yorktown Heights, NY)|
|James G. Dolan||University of Rochester (Rochester, New York, United States)|
|Simon D. Eckermann, PhD||University of Wollongong (Wollongong, New South Wales, Australia)|
|Tom Fahey, MSc, MD, DCH, DObs, MEd, MFPH||Royal College of Surgeons in Ireland (Dublin, Ireland)|
|Negin Hajizadeh, MD, MPH||New York University School of Medicine (New York, NY, USA)|
|Malek B. Hannouf, PhD||London Health Sciences Centre (London, United Kingdom)|
|David W. Hutton, PhD||University of Michigan (Ann Arbor, Michigan, United States)|
|Christopher H. Jackson, MMath, PhD||University of Cambridge (Cambridge, UK)|
|Sarah E. Lillie, MPH, PhD||Minneapolis VA Health Care System (Minneapolis, MN, USA)|
|Ankur Pandya, MPH, PhD||Harvard University (Cambridge, MA, USA)|
|Adam T. Perzynski, MA, PhD||Case Western Reserve University (Cleveland, OH, USA)|
|Mary C. Politi, PhD||Washington University in St. Louis (St. Louis, Missouri, United States)|
|Beate Sander, RN, MBA, PhD, MEcDev, PhD||Ontario Agency for Health Protection and Promotion (Toronto, ON, Canada)|
|Laura D. Scherer, PhD||University of Missouri (Columbia, Missouri, United States)|
|Matthias Schwenkglenks, PhD, MPH||University of Basel (Basel, Switzerland)|
|Djøra I. Soeteman, MSc, PhD||Harvard University (Boston, MA, USA)|
|Ben van Calster, PhD||Katholieke Universiteit Leuven (Leuven, Belgium)|
|Joost van Rosmalen, PhD||Erasmus University (Rotterdam, Netherlands)|
|Torbjørn Fosen Wisløff, MSc, PhD||Norwegian Knowledge Centre for the Health Services (Oslo, Norway)|
|Tracey Anne Young, PhD||University of Sheffield (Sheffield, United Kingdom)|
|Rebecca J. Fiala, MA||University of Illinois at Chicago (Chicago, Illinois, United States)|
MDM Policy & Practice is a member of the Committee on Publication Ethics (COPE).
Authors are strongly encouraged to review the Medical Decision Making Policy & Practice website for information on manuscript requirements, manuscript submission, and the peer review process (single blind) at MDM P&P before submitting your manuscript at https://mc.manuscriptcentral.com/mdm-pp. Please note that manuscripts not conforming to these guidelines may be returned. Only manuscripts of sufficient quality that meet the aims and scope of MDM P&P will be reviewed.
If, after peer review, your manuscript is accepted for publication, a one-time Article Processing Charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license. SMDM members pay an article processing charge of $1,340, while non-members pay an article processing charge of $1,675. This will be payable upon acceptance.
MDM P&P publishes manuscripts under the Creative Commons by Attribution Non-Commercial License (CC-BY NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author's request. Visit SAGE's OA licenses page for more information.
Please contact the MDM Editorial Office with any questions.